Xenon Pharmaceuticals (NASDAQ: XENE) reported Q1 EPS of ($0.21), $0.27 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $0 versus the consensus estimate of $100 thousand.

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.